Secondary and tertiary prevention in the management of low-trauma fracture

Size: px
Start display at page:

Download "Secondary and tertiary prevention in the management of low-trauma fracture"

Transcription

1 Secondary and tertiary prevention in the management of low-trauma fracture Tenielle A Myers and N Kathryn Briffa Curtin University of Technology, Perth A significant risk factor for osteoporotic fracture is a previous atraumatic fracture. The objective of this study was to investigate whether patients with Colles fracture from minimal trauma were subsequently identified, assessed and treated for their elevated risk of fracture. Medical records at Sir Charles Gairdner Hospital in Perth, Western Australia, from August 1999 to July 2000 were audited and 111 patients who had sustained a Colles fracture from minimal trauma were identified. Questionnaires were subsequently posted to participants to determine whether any assessment or treatment was undertaken outside the hospital system. According to documentation in the medical records, 9% (10/111) had their bone mineral density assessed, 15% (17/111) were receiving medical therapy for osteoporosis, 7% (8/111) had their falls risk assessed and 51% (58/111) were seen by a physiotherapist. Of the 58 who received physiotherapy, 76% (44/58) received upper limb exercises and 19% (11/58) received lower limb or balance exercises. Follow-up questionnaires one to two years after the fracture were returned by 43% (48/111) of the sample. By this time, 37% (18/48) had BMD assessed and 27% (13/48) were receiving medical therapy for osteoporosis. Thirty-five per cent (17/48) of patients recalled being advised to increase their calcium intake. Of those who reported more than one fall during the past 12 months, 62% (8/13) had been seen by a physiotherapist, 46% (6/13) reported having their balance assessed and 54% (7/13) reported having a home visit for assessment of rails etc. Despite the availability of effective treatments, a substantial proportion of patients with Colles fracture from minimal trauma are not being identified, assessed or treated for their elevated risk of subsequent osteoporotic fracture. [Myers TA and Briffa NK (2003): Secondary and tertiary prevention in the management of low-trauma fracture. Australian Journal of Physiotherapy 49: 25-29] Key words: Colles Fracture; Equilibrium; Osteoporosis Introduction Osteoporosis is an increasingly common health concern that affects both men and women. It manifests as fractures following minimal trauma. Lifetime fracture risk in a person aged 60 years and over is 56% for females and 29% for males (Jones et al 1994). Risk factors for osteoporotic fracture include low bone mineral density (BMD) and exposure to trauma, often as a fall (Cummings et al 1995, Earnshaw et al 1998, Greenspan et al 1994, Nguyen et al 1993). Low BMD can be accurately identified using dual energy x-ray absorptiometry (DXA; Kanis 1994). There is good evidence that pharmacological intervention is effective in treating low BMD. Effective medical therapies include hormone replacement therapy (HRT; Recker et al 1999), bisphosphonates (Karpf et al 1997), raloxifene (Ettinger et al 1999), and calcium and vitamin D (Reid 1998). Calcitriol is also used by some physicians although the data regarding its efficacy are less clear-cut (Delmas 2002). For some of these medical therapies, large controlled trials have shown that alendronate, risedronate, and raloxifene substantially reduce fracture risk (Delmas 2002). Choice of medical therapy depends on age, BMD and the presence or absence of prevalent fractures (Delmas 2002). Another strategy that has shown to be effective in increasing bone mass is exercise, particularly weight bearing exercise or resistance training, although the magnitude of change in BMD is much smaller in response to exercise than to medical therapy (Kerr et al 2001). Skeletal trauma in the aged is caused predominantly by falls and thus an elevated risk for falls is a risk factor for fracture. Thirty-three per cent of vertebral fractures are associated with falls (Cooper et al 1992). Approximately one third of the population aged 65 years and over fall each year and about 5% of these falls result in fractures (Tinetti et al 1994). Risk factors for falls include a previous history of falls, visual impairments, use of a walking aid and an elevated perceived risk of falling (Hill et al 2000). Many of these risk factors can be favourably modified with simple interventions. For example, exercises such as Tai Chi and balance training have been shown, in randomised controlled trials, to significantly reduce the risk of falling (Wolf et al 1996). Practice guidelines suggest individually tailored exercise programs conducted by qualified professionals should be established for high risk groups (Feder et al 2000) and that balance training should be one of the components (American Geriatrics Society et al 2001). As modifiable risk factors for falls are numerous, a multifactorial approach that targets specific risk factors for each individual has been shown to be very effective in reducing risk of falling (Tinetti et al 1994). Consequently, it has been recommended that programs that include more Australian Journal of Physiotherapy 2003 Vol

2 than one intervention should be prioritised (Feder et al 2000). Given the pathophysiology of osteoporotic fracture, it is not surprising that an important predictor of osteoporotic fracture is a previous osteoporotic fracture (Kanis 1994). Colles fracture is frequently a fracture of osteoporotic bone and most often results from a fall. Interestingly, Colles fracture is likely to occur on average about 15 years earlier than hip fracture (Mallmin et al 1993). Consequently, patients with Colles fracture from minimal trauma constitute a group that is suitable for screening to identify any other risk factors amenable to treatment, such as low BMD and risk of falling. The purpose of this study was to determine whether patients presenting with a Colles fracture from minimal trauma were subsequently identified as candidates for secondary prevention and consequently assessed and treated for osteoporosis and risk of falling. Table 1. Proportion of patients receiving medical therapy as documented in the medical records and according to responses on self-completed questionnaire. Medical Hospital Patient Therapy Records Questionnaire N = 111 N = 48 % n % n Any treatment 15.3 (17) 27.1(13) Hormone replacement therapy 2.7 (3) 2.1 (1) Bisphosphonates 1.8 (2) 4.2 (2) Calcitriol 2.7 (3) 4.2 (2) Calcium 7.2 (8) 14.6 (7) Vitamin D 8.1 (9) 10.4 (5) Methods Subjects Subjects were men and women treated for a Colles fracture during the 12-month period from August 1999 to July 2000 at Sir Charles Gairdner Hospital (SCGH). Cases were identified from the SCGH databases using ICD code S52.0-S52.8 and medical records were subsequently audited. Three hundred and sixteen patients were eligible for the study, however patients were excluded if they were less than 55 years old (170), if the fracture was the result of trauma more substantial than a fall from standing height (12), if the fracture was pathological (3), or if the wrist fracture was not a Colles fracture (20). The remaining 111 records were examined to extract data regarding date of birth, past medical history, medications, history of a previous fracture, whether BMD was assessed, whether falls risk was assessed and whether the participant was seen by a physiotherapist following their Colles fracture. As follow-up care is often provided outside the hospital system, the medical record audit was supplemented with a simple questionnaire posted to the 111 individuals who met the inclusion criteria. The questionnaire sought information regarding medications and the prevalence of risk factors for osteoporotic fractures such as history of previous fracture and falls, use of a walking aid, and perceived risk of falling. It was also of interest whether or not physiotherapy was received after the Colles fracture, specifically whether balance, falls history and home environment had been assessed. Prior to distribution, this questionnaire was tested in a small pilot study. Five volunteers aged at least 55 were tested to ensure the questions were correctly interpreted by the respondent and the answer provided addressed the intended question. All subjects correctly interpreted the questions and provided appropriate responses. The study was approved by the Curtin University and SCGH Human Research Ethics Committees and procedures accorded with committee requirements. Data analyses were primarily descriptive with differences in proportion tested with the chi square procedure and Fisher s exact test where expected frequencies were small. Significance was inferred where p < Results Medical record audit The study group was predominantly female (95%) with a median (IQR) age of 81 (11) years. The median age of the five men in the study group was comparable at 82 (9.3) years. In view of the relatively small number of men in the study group, no comparison of treatment between men and women was made. All the fractures were the result of a fall from standing height or less and 45 patients required inpatient admission for treatment of the fracture. Thirty-one had a previous fracture and three patients were on oral prednisolone. Only 9% (10/111) of the patients in this study group had documentation of BMD measurement in their hospital records. Fifteen per cent (17/111) were on medical therapy for osteoporosis. Table 1 shows the proportion of patients receiving medical therapy for osteoporosis. Some patients were receiving more than one therapy, five were receiving calcium and vitamin D and one was receiving calcium and calcitriol. One of the five men in the group was receiving treatment for osteoporosis, specifically calcium and vitamin D. There was no significant difference in the proportion of patients with previous fracture receiving medical therapy (22.5%) compared with those without a previous fracture (12.5%; Fisher s exact p = 0.23). Nor was 26 Australian Journal of Physiotherapy 2003 Vol. 49

3 there a significant difference in proportion of patients aged 80 years and over taking medical therapy (21.4%) compared with those less than 80 years (9.1%; Fisher s exact p = 0.11). Of the three patients on oral prednisolone, none were receiving medical therapy for osteoporosis. Eight of the patients had been identified by nursing staff using an in-house checklist of risk factors for falls as having an increased falls risk, and all of these were seen by a physiotherapist. An additional three patients were referred to the SCGH falls clinic. Fifty-two per cent of patients (58/111) were seen by a physiotherapist during either their hospitalisation or rehabilitation. Of these, 76% (44/58) received treatment to the upper limb including one or more of shoulder/elbow/wrist exercises and passive mobilisation. Lower limb exercises or balance retraining, either of which may conceivably be considered to address elevated risk of falling, were received by only 19% (11/58) of those receiving physiotherapy. Four patients received ambulation as their only documented physiotherapy treatment. Questionnaire Follow up questionnaires were sent approximately one to two years after the fracture, depending on the date of fracture, to investigate any further treatment that may have taken place outside the hospital system. Forty-eight patients completed and returned the questionnaire, six were returned for deceased patients and three were no longer at that address (51% returned). There were no significant differences between responders and non-responders in terms of age (80.5 (11) vs 79 (15.7) years respectively p = 0.49); proportion of males (2% vs 6% p = 0.38); or proportion requiring inpatient admission for management of their fracture (43% vs 37% p = 0.57). Of the 48 questionnaires returned, 37.5% (18/48) reported having their BMD assessed, and of these, 50% (9/18) were receiving medical therapy for osteoporosis. Overall, 27% (13/48) were taking some form of medical therapy for osteoporosis (Table 1). Thirty-five per cent (17/48) of patients recalled being advised to increase their calcium intake, and of these, 12 were making a conscious effort to do so. Twenty-seven per cent (13/48) of those who returned the questionnaire had fallen more than once in the preceding 12 months. Moreover, 41% (17/48) rated their risk of falling in the next six months as moderate or high. Of those with multiple falls (13), 62% (eight) had been seen by a physiotherapist, 46% (six) recalled having their balance tested, and 54% (seven) had been visited at home for assessment of rails etc. However, the proportion of patients receiving each of these assessments did not differ according to their history of falling (p > 0.2). Of the eight patients who had their falls risk assessed by nursing staff, four returned their follow-up questionnaire, and of these two had more than one fall during the follow-up period despite receiving physiotherapy for balance/muscle strength of the lower limbs. Discussion Individuals with a fracture from minimal trauma are, by virtue of that fracture, known to have an elevated risk for subsequent osteoporotic fracture (Mallmin et al 1993). Therefore, they constitute a high-risk group, ideal candidates for secondary prevention including further assessment and treatment for other risk factors for osteoporotic fracture. However, this study highlights that only a small proportion of those with a Colles fracture from minimal trauma were receiving secondary prevention. These findings are consistent with those of a recent Canadian study that found fewer than 20% of patients with fractures typical of osteoporosis report receiving investigation or treatment for osteoporosis (Hajcsar et al 2000) Dual energy x-ray absorptiometry has been recommended as the optimal measurement of BMD for predicting hip fractures (Kanis 1994). Indeed, clinical pathways recently established for the medical management of patients with low-trauma fracture recommend DXA scans among the additional diagnostic examinations to be included in the pathway (Chevally et al 2002). Although in Australia DXA scanning is not required prior to prescribing medications for fracture prevention if a minimal trauma fracture has already occurred, DXA scanning is recommended (Delmas 2002). This is particularly so for non-vertebral fractures such as Colles fracture, where determination of skeletal fragility is considered an integral part of the clinical decision making process (Delmas 2002). Despite this, just 9% of patients had documentation in the medical records of BMD measurement. One to two years after the index fracture, 37% of respondents reported having BMD assessed. The proportion who had still not been assessed is high, particularly as DXA measurements are safe, comparatively inexpensive and widely available. There is now good evidence that pharmacological intervention is effective in treating low BMD and reducing the risk of fracture (Ettinger et al 1999, Karpf et al 1997, Recker et al 1999, Reid 1998). Even so, a surprisingly small proportion of patients in this study were receiving medical therapy for osteoporosis. Similar findings were reported in a study that found patients with hip or Colles fracture did not show a statistically significant increase in the use of medical therapy compared with age-matched controls (Torgerson and Dolan 1998). In that study, medical therapy for osteoporosis was increased among only those with a vertebral fracture. It is of interest that none of the patients with vertebral fracture were receiving any of the therapies that have been shown to decrease vertebral fracture incidence (Torgerson and Dolan 1998), which further highlights that osteoporosis is not always treated optimally. Our study did not examine the proportion of patients who were offered medical therapy but declined treatment. However, with various intervention strategies available, it is Australian Journal of Physiotherapy 2003 Vol

4 reasonable to assume that those who have BMD measured but decline treatment would be advised on other, albeit less effective, forms of anti-fracture treatment, such as increasing dietary calcium intake. Yet in this study, only 61% of those who had their BMD measured recalled being advised to increase calcium in their diet. These results differ from a recent study that reported 90% of those who were diagnosed as having osteoporosis were advised to increase calcium intake (Hajcsar et al 2000). The mean age for men and women in that study was 64 years, compared with a median of 81 and 82 years for men and women in our study. The difference may reflect an age-related decline in recall or alternatively, in view of their older age, health professionals may consider it is too late to be worth initiating therapy. Cost is another possible reason for the small proportion of patients receiving medical therapy. However, medical therapy, specifically calcium and vitamin D, targeted at those at high risk has been shown to reduce overall health care costs (Torgerson and Kanis 1995). Considering the cost of osteoporotic fractures in Australia in 1992 was $779 million and this is expected to increase more than two-fold by 2025 (Randell et al 1995), the cost of investigation and treatment of osteoporosis seems justified. Physiotherapists are also failing to respond to the increased fracture risk in patients with Colles fracture, as indicated by the small proportion of patients (7%) assessed for falls risk. Risk factors for falls are well established, one being a previous history of falling (Tinetti et al 1994). Practice guidelines for falls prevention recommend that older persons who present for medical attention because of a fall should have a fall evaluation performed by a clinician with appropriate skills and experience (American Geriatrics Society et al 2001). All of the Colles fractures in this study were the result of a fall, thus all of the patients have an increased risk for falling and meet the criteria for evaluation, yet apparently few were assessed or received treatment to reduce their risk of falling. Of the patients who did receive physiotherapy, the majority (76%) received upper limb exercises that included one or more of shoulder, elbow or wrist passive and active exercises. A considerably smaller proportion (19%) received lower limb strengthening or balance training, even though numerous studies have demonstrated that balance training is effective in reducing falls risk (Tinetti et al 1994, Wolf et al 1996). However, evidence-based practice guidelines recommend multifaceted interventions including balance training for at-risk older individuals (American Geriatrics Society et al 2001, Feder et al 2000). Even of those patients who reported a history of multiple falls, and thus have an easily identifiable elevated risk for falls (Tinetti et al 1994), fewer than half were treated for balance. The results of this study suggest that physiotherapists are focusing primarily on fracture care, rather than a holistic treatment program for this group of patients. This may reflect a failure to recognise the importance of secondary prevention in this group or may relate to limited resources resulting in physiotherapists being compelled to prioritise workloads in such a way that some patients do not receive potentially beneficial assessment and treatment. It would be of interest to further explore whether physiotherapists are cognisant of their potentially important role in secondary prevention of osteoporotic fracture. Better understanding of the rationale used for prioritisation of physiotherapy treatment, particularly in the public sector, and the longer term implications of the decisions made, would also be worthwhile. Although overall the numbers in this study are relatively small, the participants and their management are likely to be typical of that in large teaching hospitals anywhere in Australia or New Zealand. However, caution would need to be applied in generalising the results from this study of those receiving treatment for their Colles fracture in the public hospital system to those receiving treatment elsewhere. Reference to Australian fracture incidence data suggests that younger individuals may be underrepresented in our sample (Sanders et al 1999). A strength of the study is that by limiting the sample to those who fractured between 1999 and 2000, the results represent contemporary practice while allowing sufficient time for implementation of secondary prevention. Unfortunately only approximately half of the questionnaires were completed and returned, so knowledge about treatment outside the hospital system is incomplete. Moreover, there is no way of knowing whether patients may have been offered treatment but declined. Our data support anecdotal impressions that many patients with Colles fracture are not receiving secondary prevention for osteoporotic fracture. Consequently they remain at unnecessarily elevated risk for subsequent osteoporotic fracture and the associated cost, morbidity, mortality and reduced quality of life. The development of a clinical pathway for use in fracture clinics may assist in improving this aspect of the management of patients with fracture from minimal trauma. Acknowledgments Mr Peter Honey, Head, Department of Orthopaedic Surgery and Associate Professor Richard Prince, Head, Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, for their support of the project. Clerical staff at Sir Charles Gairdner Hospital who assisted with identifying suitable cases and making records available. Correspondence Dr Kathy Briffa, School of Physiotherapy, Curtin University of Technology, GPO Box U1987, Perth, Western Australia k.briffa@curtin.edu.au. References American Geriatrics Society, British Geriatrics Society and American Academy of Orthopaedic Surgeons Panel on Falls Prevention (2001): Guideline for the prevention of falls in older persons. Journal of the American Geriatrics Society 49: Australian Journal of Physiotherapy 2003 Vol. 49

5 Cooper C, Atkinson E, Fallon W and Melton L (1992): Incidence of clinically diagnosed vertebral fractures: A population-based study in Rochester, Minnesota, Journal of Bone and Mineral Research 7: Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D and Vogt TM (1995): Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. New England Journal of Medicine 332: Delmas PD (2002): Treatment of postmenopausal osteoporosis. Lancet 359: Earnshaw SA, Cawte SA, Worley A and Hosking DJ (1998): Colles fracture of the wrist as an indicator of underlying osteoporosis in postmenopausal women: a prospective study of bone mineral density and bone turnover rate. Osteoporosis International 8: Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P and Cummings SR (1999): Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282: Feder G, Cryer C, Donovan S and Carter Y (2000): Guidelines for the prevention of falls in people over 65. BMJ 321: Greenspan SL, Myers ER, Maitland LA, Resnick NM and Hayes WC (1994): Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. JAMA 271: Hajcsar EE, Hawker G and Bogoch ER (2000): Investigation and treatment of osteoporosis in patients with fragility fractures. Canadian Medical Association Journal 163: Hill K, Smith R, Murray K, Sims J, Gough J, Darzins P, Vrantsidis F and Clark R (2000): An analysis of research on preventing falls and falls injury in older people: community, residential aged care and acute care settings. Melbourne: National Ageing Research Institute. Jones G, Nguyen T, Sambrook PN, Kelly PJ, Gilbert C and Eisman JA (1994): Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporosis International 4: Kanis JA (1994): Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporosis International 4: Karpf DB, Shapiro DR, Seeman E, Ensrud KE, Johnston CC, Jr, Adami S, Harris ST, Santora AC, Hirsch LJ, Oppenheimer L and Thompson D (1997): Prevention of nonvertebral fractures by alendronate. A meta-analysis. JAMA 277: Kerr D, Ackland T, Maslen B, Morton A and Prince R (2001): Resistance training over 2 years increases bone mass in calcium-replete postmenopausal women. Journal of Bone and Mineral Research 16: Mallmin H, Ljunghall S, Persson I, Naessen T, Krusemo UB and Bergstrom R (1993): Fracture of the distal forearm as a forecaster of subsequent hip fracture: a populationbased cohort study with 24 years of follow-up. Calcified Tissue International 52: Nguyen T, Sambrook P, Kelly P, Jones G, Lord S, Freund J and Eisman J (1993): Prediction of osteoporotic fractures by postural instability and bone density. BMJ 307: Randell A, Sambrook PN, Nguyen TV, Lapsley H, Jones G, Kelly PJ and Eisman JA (1995): Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporosis International 5: Recker RR, Davies KM, Dowd RM and Heaney RP (1999): The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial. Annals of Internal Medicine 130: Reid IR (1998): The roles of calcium and vitamin D in the prevention of osteoporosis. Endocrinology and Metabolism Clinics of North America 27: Sanders KM, Seeman E, Ugoni AM, Pasco JA, Martin TJ, Skoric B, Nicholson GC and Kotowicz MA (1999): Ageand gender-specific rate of fractures in Australia: A population-based study. Osteoporosis International 10: Tinetti ME, Baker DI, McAvay G, Claus EB, Garrett P, Gottschalk M, Koch ML, Trainor K and Horwitz RI (1994): A multifactorial intervention to reduce the risk of falling among elderly people living in the community. New England Journal of Medicine 331: Torgerson DJ and Dolan P (1998): Prescribing by general practitioners after an osteoporotic fracture. Annals of the Rheumatic Diseases 57: Torgerson DJ and Kanis JA (1995): Cost-effectiveness of preventing hip fractures in the elderly population using vitamin D and calcium. QJM 88: Wolf SL, Barnhart HX, Kutner NG, McNeely E, Coogler C and Xu T (1996): Reducing frailty and falls in older persons: an investigation of Tai Chi and computerized balance training. Atlanta FICSIT Group. Frailty and Injuries: Cooperative Studies of Intervention Techniques. Journal of the American Geriatrics Society 44: Australian Journal of Physiotherapy 2003 Vol

Submission to the National Institute for Clinical Excellence on

Submission to the National Institute for Clinical Excellence on Submission to the National Institute for Clinical Excellence on Strontium ranelate for the prevention of osteoporotic fractures in postmenopausal women with osteoporosis by The Society for Endocrinology

More information

Can we improve the compliance to prevention treatment after a wrist fracture? Roy Kessous

Can we improve the compliance to prevention treatment after a wrist fracture? Roy Kessous Can we improve the compliance to prevention treatment after a wrist fracture? Roy Kessous Distal radius fracture in women after menopause is in many cases a first clinical indication for the presence of

More information

Risedronate prevents hip fractures, but who should get therapy?

Risedronate prevents hip fractures, but who should get therapy? INTERPRETING KEY TRIALS CHAD L. DEAL, MD Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic THE HIP TRIAL Risedronate prevents

More information

ORIGINAL ARTICLE. E. Barrett-Connor & S. G. Sajjan & E. S. Siris & P. D. Miller & Y.-T. Chen & L. E. Markson

ORIGINAL ARTICLE. E. Barrett-Connor & S. G. Sajjan & E. S. Siris & P. D. Miller & Y.-T. Chen & L. E. Markson Osteoporos Int (2008) 19:607 613 DOI 10.1007/s00198-007-0508-8 ORIGINAL ARTICLE Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National

More information

Postmenopausal osteoporosis is a systemic

Postmenopausal osteoporosis is a systemic OSTEOPOROSIS: HARD FACTS ABOUT BONES Steven T. Harris, MD, FACP* ABSTRACT As a consequence of the aging process, osteoporosis affects all men and women. Agerelated loss of bone mass leads to skeletal fragility

More information

OSTEOPOROSIS MANAGEMENT AND INVESTIGATION. David A. Hanley, MD, FRCPC

OSTEOPOROSIS MANAGEMENT AND INVESTIGATION. David A. Hanley, MD, FRCPC OSTEOPOROSIS MANAGEMENT AND INVESTIGATION David A. Hanley, MD, FRCPC There is a huge care gap in the management of osteoporosis in this country. As yet unpublished findings from the Canadian Multicentre

More information

Original Article. Ramesh Keerthi Gadam, MD 1 ; Karen Schlauch, PhD 2 ; Kenneth E. Izuora, MD, MBA 1 ABSTRACT

Original Article. Ramesh Keerthi Gadam, MD 1 ; Karen Schlauch, PhD 2 ; Kenneth E. Izuora, MD, MBA 1 ABSTRACT Original Article Ramesh Keerthi Gadam, MD 1 ; Karen Schlauch, PhD 2 ; Kenneth E. Izuora, MD, MBA 1 ABSTRACT Objective: To compare Fracture Risk Assessment Tool (FRAX) calculations with and without bone

More information

NIH Public Access Author Manuscript Endocr Pract. Author manuscript; available in PMC 2014 May 11.

NIH Public Access Author Manuscript Endocr Pract. Author manuscript; available in PMC 2014 May 11. NIH Public Access Author Manuscript Published in final edited form as: Endocr Pract. 2013 ; 19(5): 780 784. doi:10.4158/ep12416.or. FRAX Prediction Without BMD for Assessment of Osteoporotic Fracture Risk

More information

DECADES OF PUBLISHED STUDIES have confirmed the

DECADES OF PUBLISHED STUDIES have confirmed the JOURNAL OF BONE AND MINERAL RESEARCH Volume 15, Number 2, 2000 2000 American Society for Bone and Mineral Research Perspective Bone Matters: Are Density Increases Necessary to Reduce Fracture Risk? KENNETH

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research  ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Osteoporosis- Do We Need to Think Beyond Bone Mineral Density? Dr Preeti Soni 1, Dr Shipra

More information

An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines

An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines Osteoporos Int (2006) 17: 1111 1115 DOI 10.1007/s00198-006-0101-6 SHORT COMMUNICATION An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines R. Baddoura. H. Awada. J. Okais.

More information

Fall-related risk factors and osteoporosis in older women referred to an open access bone densitometry service

Fall-related risk factors and osteoporosis in older women referred to an open access bone densitometry service Age and Ageing 05; 34: 67 71 Age and Ageing Vol. 34 No. 1 British Geriatrics Society 04; all rights reserved doi:10.1093/ageing/afh238 Published electronically 15 November 04 Fall-related risk factors

More information

This house believes that HRT should be the first-line prevention for postmenopausal osteoporosis: the case against

This house believes that HRT should be the first-line prevention for postmenopausal osteoporosis: the case against This house believes that HRT should be the first-line prevention for postmenopausal osteoporosis: the case against Juliet Compston Professor of Bone Medicine University of Cambridge School of Clinical

More information

An audit of osteoporotic patients in an Australian general practice

An audit of osteoporotic patients in an Australian general practice professional Darren Parker An audit of osteoporotic patients in an Australian general practice Background Osteoporosis is a major contributor to morbidity and mortality in Australia, and is predicted to

More information

The Significance of Vertebral Fractures

The Significance of Vertebral Fractures Special Report The Significance of Vertebral Fractures Both the prevalence and the clinical significance of vertebral fractures has been greatly underestimated by physicians. Vertebral fractures are much

More information

nogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK

nogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK nogg NATIONAL OSTEOPOROSIS GUIDELINE GROUP Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK Produced by J Compston, A Cooper,

More information

Body Mass Index as Predictor of Bone Mineral Density in Postmenopausal Women in India

Body Mass Index as Predictor of Bone Mineral Density in Postmenopausal Women in India International Journal of Public Health Science (IJPHS) Vol.3, No.4, December 2014, pp. 276 ~ 280 ISSN: 2252-8806 276 Body Mass Index as Predictor of Bone Mineral Density in Postmenopausal Women in India

More information

Horizon Scanning Centre March Denosumab for glucocorticoidinduced SUMMARY NIHR HSC ID: 6329

Horizon Scanning Centre March Denosumab for glucocorticoidinduced SUMMARY NIHR HSC ID: 6329 Horizon Scanning Centre March 2014 Denosumab for glucocorticoidinduced osteoporosis SUMMARY NIHR HSC ID: 6329 This briefing is based on information available at the time of research and a limited literature

More information

Dr Tuan V NGUYEN. Mapping Translational Research into Individualised Prognosis of Fracture Risk

Dr Tuan V NGUYEN. Mapping Translational Research into Individualised Prognosis of Fracture Risk Dr Tuan V NGUYEN Bone and Mineral Research Program, Garvan Institute of Medical Research, Sydney NSW Mapping Translational Research into Individualised Prognosis of Fracture Risk From the age of 60, one

More information

Tamer Mettyas 1* and Clare Carpenter 2

Tamer Mettyas 1* and Clare Carpenter 2 Mettyas and Carpenter Journal of Orthopaedic Surgery and Research 2013, 8:44 RESEARCH ARTICLE Open Access Secondary prevention of osteoporosis in non-neck of femur fragility : is it value for money? A

More information

Objectives. Discuss bone health and the consequences of osteoporosis on patients medical and disability status.

Objectives. Discuss bone health and the consequences of osteoporosis on patients medical and disability status. Objectives Discuss bone health and the consequences of osteoporosis on patients medical and disability status. Discuss the pathophysiology of osteoporosis and major risk factors. Assess the major diagnostic

More information

Osteoporosis. Overview

Osteoporosis. Overview v2 Osteoporosis Overview Osteoporosis is defined as compromised bone strength that increases risk of fracture (NIH Consensus Conference, 2000). Bone strength is characterized by bone mineral density (BMD)

More information

SCHEDULE 2 THE SERVICES. A. Service Specifications

SCHEDULE 2 THE SERVICES. A. Service Specifications SCHEDULE 2 THE SERVICES A. Service Specifications Service Specification No. 04/MSKT/0013 Service PAN DORSET FRACTURE LIAISON SERVICE Commissioner Lead CCP for Musculoskeletal & Trauma Provider Lead Deputy

More information

Management of postmenopausal osteoporosis

Management of postmenopausal osteoporosis Management of postmenopausal osteoporosis Yeap SS, Hew FL, Chan SP, on behalf of the Malaysian Osteoporosis Society Committee Working Group for the Clinical Guidance on the Management of Osteoporosis,

More information

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study Rheumatol Int (2006) 26: 427 431 DOI 10.1007/s00296-005-0004-4 ORIGINAL ARTICLE J. D. Ringe Æ H. Faber Æ P. Farahmand Æ A. Dorst Efficacy of risedronate in men with primary and secondary osteoporosis:

More information

1.2 Health states/risk factors affected by the intervention

1.2 Health states/risk factors affected by the intervention 1.1 Definition of intervention The intervention is opportunistic screening for low bone mineral density (BMD) for women aged 70 to 90 years who present to their GP for an unrelated purpose, and subsequent

More information

BAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008

BAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008 BAD TO THE BONE Peter Jones, Rheumatologist QE Health, Rotorua GP CME Conference Rotorua, June 2008 Agenda Osteoporosis in Men Vitamin D and Calcium Long-term treatment with Bisphosphonates Pathophysiology

More information

The recent publication of guidance from the National

The recent publication of guidance from the National 216 Clinical Pharmacist May 2009 Vol 1 Several guidelines exist for the identification and treatment of osteoporosis. Patients diagnosed with the condition should be prescribed bisphosphonates, if suitable,

More information

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment William D. Leslie, MD MSc FRCPC Case #1 Age 53: 3 years post-menopause Has always enjoyed excellent health with

More information

Osteoporosis is estimated to develop in 1 out of 4 women over the age of 50. Influence of bone densitometry results on the treatment of osteoporosis

Osteoporosis is estimated to develop in 1 out of 4 women over the age of 50. Influence of bone densitometry results on the treatment of osteoporosis Influence of bone densitometry results on the treatment of osteoporosis Nicole S. Fitt, * Susan L. Mitchell, * Ann Cranney, Karen Gulenchyn, Max Huang, * Peter Tugwell Abstract Background: Measurement

More information

International Journal of Advanced Research in Biological Sciences ISSN : Research Article

International Journal of Advanced Research in Biological Sciences ISSN : Research Article Int. J. Adv. Res. Biol.Sci. 1(7): (2014): 167 172 International Journal of Advanced Research in Biological Sciences ISSN : 2348-8069 www.ijarbs.com Research Article Beneficial effect of Strontium Ranelate

More information

Download slides:

Download slides: Download slides: https://www.tinyurl.com/m67zcnn https://tinyurl.com/kazchbn OSTEOPOROSIS REVIEW AND UPDATE Boca Raton Regional Hospital Internal Medicine Conference 2017 Benjamin Wang, M.D., FRCPC Division

More information

Distal Radius Fracture Risk Reduction With a Comprehensive Osteoporosis Management Program

Distal Radius Fracture Risk Reduction With a Comprehensive Osteoporosis Management Program SCIENTIFIC ARTICLE Distal Radius Fracture Risk Reduction With a Comprehensive Osteoporosis Management Program Neil G. Harness, MD, Tadashi Funahashi, MD, Richard Dell, MD, Annette L. Adams, PhD, MPH, Raoul

More information

Discovering prior fractures in your postmenopausal patient may be the LINK to reducing her fragility fracture* risk in the future.

Discovering prior fractures in your postmenopausal patient may be the LINK to reducing her fragility fracture* risk in the future. Discovering prior fractures in your postmenopausal patient may be the LINK to reducing her fragility fracture* risk in the future. *A fragility fracture is defined as a fracture caused by minimal trauma,

More information

Skeletal Manifestations

Skeletal Manifestations Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes

More information

Oral Alendronate Vs. Three-Monthly Iv Ibandronate In The Treatment Of Postmenopausal Osteoporosis

Oral Alendronate Vs. Three-Monthly Iv Ibandronate In The Treatment Of Postmenopausal Osteoporosis Oral Alendronate Vs. Three-Monthly Iv Ibandronate In The Treatment Of Postmenopausal Osteoporosis Miriam Silverberg A. Study Purpose and Rationale More than 70% of fractures in people after the age of

More information

Effectiveness of Strategies for the Secondary Prevention of Osteoporotic Fractures in Scotland. Executive Summary

Effectiveness of Strategies for the Secondary Prevention of Osteoporotic Fractures in Scotland. Executive Summary Effectiveness of Strategies for the Secondary Prevention of Osteoporotic Fractures in Scotland Executive Summary Dr Alastair R. McLellan Professor David M. Reid Ms Kay Forbes Ms Rosie Reid Dr Clare Campbell

More information

Osteoporosis/Fracture Prevention

Osteoporosis/Fracture Prevention Osteoporosis/Fracture Prevention NATIONAL GUIDELINE SUMMARY This guideline was developed using an evidence-based methodology by the KP National Osteoporosis/Fracture Prevention Guideline Development Team

More information

Differentiating Pharmacological Therapies for Osteoporosis

Differentiating Pharmacological Therapies for Osteoporosis Differentiating Pharmacological Therapies for Osteoporosis Socrates E Papapoulos Department of Endocrinology & Metabolic Diseases Leiden University Medical Center The Netherlands Competing interests: consulting/speaking

More information

Guidelines for the Pharmaceutical Management of Osteoporosis in Adult WA Public Hospitals

Guidelines for the Pharmaceutical Management of Osteoporosis in Adult WA Public Hospitals WA.DRUG EVALUATION PANEL Guidelines for the Pharmaceutical Management of Osteoporosis in Adult WA Public Hospitals Introduction Osteoporotic fracture-related hospitalisations impose a substantial financial

More information

A prospective evaluation of bone mineral density measurement in females who have fallen

A prospective evaluation of bone mineral density measurement in females who have fallen Age and Ageing 2003; 32: 497 502 Age and Ageing Vol. 32 No. 5 British Geriatrics Society 2003; all rights reserved A prospective evaluation of bone mineral density measurement in females who have fallen

More information

Assessment and Treatment of Osteoporosis Professor T.Masud

Assessment and Treatment of Osteoporosis Professor T.Masud Assessment and Treatment of Osteoporosis Professor T.Masud Nottingham University Hospitals NHS Trust University of Nottingham University of Derby University of Southern Denmark What is Osteoporosis? Osteoporosis

More information

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Challenging the Current Osteoporosis Guidelines Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Whom to screen Which test How to diagnose Whom to treat Benefits

More information

OSTEOPOROSIS: PREVENTION AND MANAGEMENT

OSTEOPOROSIS: PREVENTION AND MANAGEMENT OSTEOPOROSIS: OVERVIEW OSTEOPOROSIS: PREVENTION AND MANAGEMENT Judith Walsh, MD, MPH Departments of Medicine and Epidemiology and Biostatistics UCSF Definitions Key Risk factors Screening and Monitoring

More information

Osteoporosis in Men. Until recently, the diagnosis of osteoporosis. A New Type of Patient. Al s case. How is the diagnosis made?

Osteoporosis in Men. Until recently, the diagnosis of osteoporosis. A New Type of Patient. Al s case. How is the diagnosis made? A New Type of Patient Rafat Faraawi, MD, FRCP(C), FACP Until recently, the diagnosis of osteoporosis in men was uncommon and, when present, it was typically described as a consequence of secondary causes.

More information

ASJ. How Many High Risk Korean Patients with Osteopenia Could Overlook Treatment Eligibility? Asian Spine Journal. Introduction

ASJ. How Many High Risk Korean Patients with Osteopenia Could Overlook Treatment Eligibility? Asian Spine Journal. Introduction Asian Spine Journal Asian Spine Clinical Journal Study Asian Spine J 2014;8(6):729-734 High http://dx.doi.org/10.4184/asj.2014.8.6.729 risk patients with osteopenia How Many High Risk Korean Patients with

More information

Osteoporosis. Current Trend in Osteoporosis Management for Elderly in HK- Medical Perspective. Old Definition of Osteoporosis

Osteoporosis. Current Trend in Osteoporosis Management for Elderly in HK- Medical Perspective. Old Definition of Osteoporosis Current Trend in Osteoporosis Management for Elderly in HK- Medical Perspective Dr Dicky T.K. Choy Physician Jockey Club Centre for Osteoporosis Care and Control, CUHK Osteoporosis Global public health

More information

Page 1

Page 1 Osteoporosis Osteoporosis is a condition characterised by weakened bones that fracture easily. After menopause many women are at risk of developing osteoporosis. Peak bone mass is usually reached during

More information

BEST PRACTICE FRAMEWORK QUESTIONNAIRE

BEST PRACTICE FRAMEWORK QUESTIONNAIRE CAPTURE the FRACTURE BEST PRACTICE FRAMEWORK QUESTIONNAIRE INTRODUCTION Capture the Fracture invites Fracture Liaison Services (FLS) to apply for Capture the Fracture Best Practice Recognition programme.

More information

Clinician s Guide to Prevention and Treatment of Osteoporosis

Clinician s Guide to Prevention and Treatment of Osteoporosis Clinician s Guide to Prevention and Treatment of Osteoporosis Published: 15 August 2014 committee of the National Osteoporosis Foundation (NOF) Tipawan khiemsontia,md outline Basic pathophysiology screening

More information

Topic 7 supplement strategies to improve hip fracture prevention and care

Topic 7 supplement strategies to improve hip fracture prevention and care This supplementary information for Topic 7 introduces the national strategy proposed by Osteoporosis New Zealand, and is one of the readings required for the professional development activity. Policymakers,

More information

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS 4:30-5:15pm Ask the Expert: Osteoporosis SPEAKERS Silvina Levis, MD OSTEOPOROSIS - FACTS 1:3 older women and 1:5 older men will have a fragility fracture after age 50 After 3 years of treatment, depending

More information

Osteoporosis International. Original Article. Bone Mineral Density and Vertebral Fractures in Men

Osteoporosis International. Original Article. Bone Mineral Density and Vertebral Fractures in Men Osteoporos Int (1999) 10:265 270 ß 1999 International Osteoporosis Foundation and National Osteoporosis Foundation Osteoporosis International Original Article Bone Mineral Density and Vertebral Fractures

More information

Quality and Outcomes Framework Programme NICE cost impact statement July Indicator area: Osteoporosis - fragility fracture

Quality and Outcomes Framework Programme NICE cost impact statement July Indicator area: Osteoporosis - fragility fracture Quality and Outcomes Framework Programme NICE cost impact statement July 2011 Indicator area: Osteoporosis - fragility fracture Indicators NM29: The practice can produce a register of patients: 1. Aged

More information

Osteoporosis: An Overview. Carolyn J. Crandall, MD, MS

Osteoporosis: An Overview. Carolyn J. Crandall, MD, MS Osteoporosis: An Overview Carolyn J. Crandall, MD, MS Osteoporosis: An Overview Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Objectives Review osteoporosis

More information

Using computers to identify non-compliant people at increased risk of osteoporotic fractures in general practice: a cross-sectional study

Using computers to identify non-compliant people at increased risk of osteoporotic fractures in general practice: a cross-sectional study Osteoporos Int (2006) 17:1808 1814 DOI 10.1007/s00198-006-0188-9 ORIGINAL ARTICLE Using computers to identify non-compliant people at increased risk of osteoporotic fractures in general practice: a cross-sectional

More information

New York State County Comparison of Fall-related Hip Fractures of Older Adults and Number of Dual-X-ray Absorptiometry Machines

New York State County Comparison of Fall-related Hip Fractures of Older Adults and Number of Dual-X-ray Absorptiometry Machines New York State County Comparison of Fall-related Hip Fractures of Older Adults and Number of Dual-X-ray Absorptiometry Machines Michael Bauer New York State Department of Health Bureau of Occupational

More information

Increased mortality after fracture of the surgical neck of the humerus: a case-control study of 253 patients with a 12-year follow-up.

Increased mortality after fracture of the surgical neck of the humerus: a case-control study of 253 patients with a 12-year follow-up. Increased mortality after fracture of the surgical neck of the humerus: a case-control study of 253 patients with a 12-year follow-up. Olsson, Christian; Petersson, Claes; Nordquist, Anders Published in:

More information

Osteoporosis Physician Performance Measurement Set. October 2006 Coding Reviewed and Updated November 2009

Osteoporosis Physician Performance Measurement Set. October 2006 Coding Reviewed and Updated November 2009 American Academy of Family Physicians/American Academy of Orthopaedic Surgeons/American Association of Clinical Endocrinologists/American College of Rheumatology/The Endocrine Society/Physician Consortium

More information

CAROLYN M. KLOTZBUECHER, PHILIP D. ROSS, PAMELA B. LANDSMAN, THOMAS A. ABBOTT III, and MARC BERGER ABSTRACT

CAROLYN M. KLOTZBUECHER, PHILIP D. ROSS, PAMELA B. LANDSMAN, THOMAS A. ABBOTT III, and MARC BERGER ABSTRACT JOURNAL OF BONE AND MINERAL RESEARCH Volume 15, Number 4, 2000 2000 American Society for Bone and Mineral Research Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of

More information

Bone Mineral Density and Its Associated Factors in Naresuan University Staff

Bone Mineral Density and Its Associated Factors in Naresuan University Staff Naresuan University Journal 2005; 13(3): 13-18 13 Bone Mineral Density and Its Associated Factors in Naresuan University Staff Supawitoo Sookpeng *, Patsuree Cheebsumon, Malinee Dhanarun, Thanyavee Pengpan

More information

AACE/ACE Osteoporosis Treatment Decision Tool

AACE/ACE Osteoporosis Treatment Decision Tool AACE/ACE Osteoporosis Treatment Decision Tool What is Osteoporosis? OSTEOPOROSIS is defined as reduced bone strength leading to an increased risk of fracture. Osteoporosis, or porous bones, occurs when

More information

PROCTER & GAMBLE and SANOFI-AVENTIS v ROCHE and GLAXOSMITHKLINE

PROCTER & GAMBLE and SANOFI-AVENTIS v ROCHE and GLAXOSMITHKLINE CASES AUTH/1803/2/06 and AUTH/1804/2/06 PROCTER & GAMBLE and SANOFI-AVENTIS v ROCHE and GLAXOSMITHKLINE Bonviva Once Monthly slide kits Procter & Gamble and Sanofi-Aventis complained jointly about two

More information

NSW & ACT. Osteoporosis costing NSW & ACT: A burden of disease analysis 2012 to 2022

NSW & ACT. Osteoporosis costing NSW & ACT: A burden of disease analysis 2012 to 2022 NSW & ACT Authors Kerrie M Sanders, Jennifer J Watts, Julie Abimanyi-Ochom, Ghulam Murtaza Osteoporosis costing NSW & ACT: A burden of disease analysis 2012 to 2022 Osteoporosis costing NSW & ACT A burden

More information

Does raloxifene (Evista) prevent fractures in postmenopausal women with osteoporosis?

Does raloxifene (Evista) prevent fractures in postmenopausal women with osteoporosis? FPIN's Clinical Inquiries Raloxifene for Prevention of Osteoporotic Fractures Clinical Inquiries provides answers to questions submitted by practicing family physicians to the Family Physicians Inquiries

More information

QUEENSLAND. Osteoporosis costing Queensland: A burden of disease analysis 2012 to 2022

QUEENSLAND. Osteoporosis costing Queensland: A burden of disease analysis 2012 to 2022 QUEENSLAND Authors Kerrie M Sanders, Jennifer J Watts, Julie Abimanyi-Ochom, Ghulam Murtaza Osteoporosis costing Queensland: A burden of disease analysis 2012 to 2022 Osteoporosis costing Queensland A

More information

ORIGINAL INVESTIGATION. Limb Fractures in Elderly Men as Indicators of Subsequent Fracture Risk

ORIGINAL INVESTIGATION. Limb Fractures in Elderly Men as Indicators of Subsequent Fracture Risk ORIGINAL INVESTIGATION Limb Fractures in Elderly Men as Indicators of Subsequent Fracture Risk Bruce Ettinger, MD; G. Thomas Ray, MBA; Alice R. Pressman, MS; Oscar Gluck, MD Background: Whether limb fracture

More information

Osteoporosis: Are your bones at risk of fracturing? Rachel Wallwork, MD Internal medicine resident Massachusetts General Hospital

Osteoporosis: Are your bones at risk of fracturing? Rachel Wallwork, MD Internal medicine resident Massachusetts General Hospital Osteoporosis: Are your bones at risk of fracturing? Rachel Wallwork, MD Internal medicine resident Massachusetts General Hospital What is Osteoporosis? Osteoporosis causes bones to lose density, become

More information

AMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT. Committee on Rheumatologic Care

AMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT. Committee on Rheumatologic Care AMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT SUBJECT: PRESENTED BY: FOR DISTRIBUTION TO: Bone Mineral Density Measurement and the Role of Rheumatologists in the Management of Osteoporosis Committee

More information

Men and Osteoporosis So you think that it can t happen to you

Men and Osteoporosis So you think that it can t happen to you Men and Osteoporosis So you think that it can t happen to you Jonathan D. Adachi MD, FRCPC Alliance for Better Bone Health Chair in Rheumatology Professor, Department of Medicine Michael G. DeGroote School

More information

Osteoporosis is a disease that is

Osteoporosis is a disease that is Pharmacologic Prevention of Osteoporotic Fractures THOMAS M. ZIZIC, M.D., Johns Hopkins University School of Medicine, Baltimore, Maryland Osteoporosis is characterized by low bone mineral density and

More information

Nutritional Aspects of Osteoporosis Care and Treatment Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, Ohio

Nutritional Aspects of Osteoporosis Care and Treatment Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, Ohio Osteoporosis 1 Nutritional Aspects of Osteoporosis Care and Treatment Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, Ohio 1) Objectives: a) To understand bone growth and development

More information

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey Fragile Bones and how to recognise them Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey Osteoporosis Osteoporosis is a skeletal disorder characterised by compromised bone

More information

WESTERN AUSTRALIA. Osteoporosis costing Western Australia: A burden of disease analysis 2012 to 2022

WESTERN AUSTRALIA. Osteoporosis costing Western Australia: A burden of disease analysis 2012 to 2022 WESTERN AUSTRALIA Authors Kerrie M Sanders, Jennifer J Watts, Julie Abimanyi-Ochom, Ghulam Murtaza Osteoporosis costing Western Australia: A burden of disease analysis 2012 to 2022 Osteoporosis costing

More information

Learning Objectives. Controversies in Osteoporosis Prevention and Management. Etiology. Presenter Disclosure Information. Epidemiology.

Learning Objectives. Controversies in Osteoporosis Prevention and Management. Etiology. Presenter Disclosure Information. Epidemiology. 12:45 1:30pm Controversies in Osteoporosis Prevention and Management SPEAKER Carolyn Crandall, MD, MS Presenter Disclosure Information The following relationships exist related to this presentation: Carolyn

More information

Setting The setting was secondary care. The economic study was carried out in Sweden.

Setting The setting was secondary care. The economic study was carried out in Sweden. Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE study Borgstrom F, Johnell O, Kanis J A, Oden A, Sykes D, Jonsson B Record Status This

More information

To understand bone growth and development across the lifespan. To develop a better understanding of osteoporosis.

To understand bone growth and development across the lifespan. To develop a better understanding of osteoporosis. Nutrition Aspects of Osteoporosis Care and Treatment t Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, OH. Objectives To understand bone growth and development across the lifespan.

More information

Guideline for the investigation and management of osteoporosis. for hospitals and General Practice

Guideline for the investigation and management of osteoporosis. for hospitals and General Practice Guideline for the investigation and management of osteoporosis for hospitals and General Practice Background Low bone density is an important risk factor for fracture. The aim of assessing bone density

More information

Analyses of cost-effective BMD scanning and treatment strategies for generic alendronate, and the costeffectiveness

Analyses of cost-effective BMD scanning and treatment strategies for generic alendronate, and the costeffectiveness Analyses of cost-effective BMD scanning and treatment strategies for generic alendronate, and the costeffectiveness of risedronate and strontium ranelate in those people who would be treated with generic

More information

BEST PRACTICE FRAMEWORK

BEST PRACTICE FRAMEWORK IOF CAPTURE the FRACTURE BEST PRACTICE FRAMEWORK for FRACTURE LIAISON SERVICES Setting the standard Studies have shown that Fracture Liaison Service models are the most cost-effective in preventing secondary

More information

Summary. Background. Diagnosis

Summary. Background. Diagnosis March 2009 Management of post-menopausal osteoporosis This bulletin focuses on the pharmacological management of patients with post-menopausal osteoporosis both those with clinically evident disease (e.g.

More information

Bone mineral density testing: Is a T score enough to determine the screening interval?

Bone mineral density testing: Is a T score enough to determine the screening interval? Interpreting Key Trials CME CREDIT EDUCATIONAL OBJECTIVE: Readers will measure bone mineral density at reasonable intervals in their older postmenopausal patients Krupa B. Doshi, MD, CCD Department of

More information

How to start and expand Fracture Liaison Services

How to start and expand Fracture Liaison Services How to start and expand Fracture Liaison Services The International Osteoporosis Foundation (IOF) Capture the Fracture Campaign has recognized that development of Fracture Liaison Services (FLS) may occur

More information

Roche Products Pty Limited and GlaxoSmithKline

Roche Products Pty Limited and GlaxoSmithKline October 2006 Breaking Point The economic cost of not adhering to bisphosphonate treatment for osteoporosis Report by Access Economics Pty Limited for Roche Products Pty Limited and GlaxoSmithKline TABLE

More information

Osteoporosis Physician Performance Measurement Set. October 2006

Osteoporosis Physician Performance Measurement Set. October 2006 American Academy of Family Physicians/American Academy of Orthopaedic Surgeons/American Association of Clinical Endocrinologists/American College of Rheumatology/The Endocrine Society/Physician Consortium

More information

ORIGINAL INVESTIGATION. Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures

ORIGINAL INVESTIGATION. Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures ORIGINAL INVESTIGATION Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures Ethel S. Siris, MD; Ya-Ting Chen, PhD; Thomas A. Abbott, PhD; Elizabeth Barrett-Connor, MD;

More information

Healthy Bones: Osteoporosis Management. Laurel Short, MSN, FNP-C

Healthy Bones: Osteoporosis Management. Laurel Short, MSN, FNP-C Healthy Bones: Osteoporosis Management Laurel Short, MSN, FNP-C Disclosure I have no current affiliation or financial interest with any grantor or commercial interests that may have direct interest in

More information

Bone Density Measurement in Women

Bone Density Measurement in Women Bone Density Measurement in Women Revised 2005 Scope This guideline defines the medical necessity of bone mineral density (BMD) measurement using dualenergy x-ray absorptiometry (DXA or DEXA), and applies

More information

Prevention of Osteoporotic Hip Fracture

Prevention of Osteoporotic Hip Fracture Prevention of Osteoporotic Hip Fracture Dr Law Sheung Wai 8th July 2007 Associate Consultant Spine team / Orthopedic Rehabilitation Department of Orthopedics and Traumatology NTE Cluster 1 Objectives Problems

More information

Male osteoporosis: clinical approach and management in family practice

Male osteoporosis: clinical approach and management in family practice Singapore Med J 2014; 55(7): 353-357 doi: 10.11622/smedj.2014085 CMEArticle Male osteoporosis: clinical approach and management in family practice Lay Hoon Goh 1,2, MMed, FCFP, Choon How How 1, MMed, FCFP,

More information

Objectives: What is Osteoporosis 10/8/2015. Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING

Objectives: What is Osteoporosis 10/8/2015. Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING TIFFANY PAUL, APN, CNP, CCD Objectives: Review the diagnosis of Osteoporosis Describe the basics of a bone density exam Identify

More information

Costing statement: Denosumab for the prevention of osteoporotic fractures in postmenopausal women

Costing statement: Denosumab for the prevention of osteoporotic fractures in postmenopausal women Costing statement: Denosumab for the prevention of osteoporotic fractures in postmenopausal women Resource impact The guidance Denosumab for the prevention of osteoporotic fractures in postmenopausal women

More information

Advanced medicine conference. Monday 20 Tuesday 21 June 2016

Advanced medicine conference. Monday 20 Tuesday 21 June 2016 Advanced medicine conference Monday 20 Tuesday 21 June 2016 Osteoporosis: recent advances in risk assessment and management Juliet Compston Emeritus Professor of Bone Medicine Cambridge Biomedical Campus

More information

Current Issues in Osteoporosis

Current Issues in Osteoporosis Current Issues in Osteoporosis California AACE 18TH Annual Meeting & Symposium Marina del Rey, CA September 15, 2018 Michael R. McClung, MD, FACP,FACE Director, Oregon Osteoporosis Center Portland, Oregon,

More information

Setting The setting was primary care. The economic study was carried out in the USA.

Setting The setting was primary care. The economic study was carried out in the USA. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women Schousboe J T, Ensrud K E, Nyman J A, Melton L J,

More information

Osteoporosis - recent advances in diagnosis and treatment

Osteoporosis - recent advances in diagnosis and treatment Title Osteoporosis - recent advances in diagnosis and treatment Author(s) Kung, AWC Citation The 4th Medical Research Conference (MRC 1999), Hong Kong, China, 30-31 January 1999. In Hong Kong Practitioner,

More information

Bisphosphonate treatment break

Bisphosphonate treatment break Bulletin 110 December 2015 Bisphosphonate treatment break Bisphosphonates have been widely used in the treatment of osteoporosis with robust data demonstrating efficacy in fracture risk reduction over

More information

Appendix G How to start and expand Fracture Liaison Services

Appendix G How to start and expand Fracture Liaison Services 1 Appendix G How to start and expand Fracture Liaison Services The International Osteoporosis Foundation (IOF) Capture the Fracture Campaign has recognized that development of Fracture Liaison Services

More information

SERMS, Hormone Therapy and Calcitonin

SERMS, Hormone Therapy and Calcitonin SERMS, Hormone Therapy and Calcitonin Tiffany Kim, MD Clinical Fellow VA Advanced Women s Health UCSF Endocrinology and Metabolism I have nothing to disclose Thanks to Clifford Rosen and Steven Cummings

More information